Mesa Laboratories (MLAB) SEC Filings & 10K Form

$103.19
+1.39 (+1.37%)
(As of 04/26/2024 ET)

Recent Mesa Laboratories SEC Filings

DateFilerForm TypeView
04/08/2024
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
8:50 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:57 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:40 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:46 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
12:41 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
11:51 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
12:10 PM
Capone Mark Christopher (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
10:37 AM
Capone Mark Christopher (Reporting)
Mesa Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2024
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:01 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/23/2024
1:18 PM
Mesa Laboratories (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SC 13G/A
01/22/2024
2:52 PM
BlackRock Inc. (Filed by)
Mesa Laboratories (Subject)
Form SC 13G/A
01/08/2024
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
8:48 AM
Conestoga Capital Advisors, LLC (Filed by)
Mesa Laboratories (Subject)
Form SC 13G/A
12/19/2023
10:21 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
9:21 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
5:11 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
7:00 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2023
12:26 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
11:42 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
11:34 AM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
12:47 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:44 PM
Mesa Laboratories (Subject)
Schmieder John Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
11:26 AM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:36 AM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:15 AM
Alltoft Jennifer Sadie (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
10:59 AM
Mesa Laboratories (Issuer)
Tripeny R Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:06 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
4:11 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:34 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
11:45 AM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2023
2:31 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
1:36 PM
Mesa Laboratories (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/25/2023
3:32 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
2:54 PM
Mesa Laboratories (Issuer)
Tripeny R Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:45 PM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:37 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:19 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:28 PM
Alltoft Jennifer Sadie (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
08/16/2023
1:03 PM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:00 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/14/2023
7:00 AM
Mesa Laboratories (Filer)
Form DEF 14A
07/03/2023
9:27 AM
Mesa Laboratories (Filer)
Form PRE 14A
06/26/2023
9:39 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
9:45 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
9:29 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
12:38 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
12:22 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
11:23 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
11:02 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:56 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:46 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:37 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:10 PM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
5:24 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
7:01 AM
Mesa Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/25/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MLAB) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners